On October 8, 2026, Pacira BioSciences surged 44.4% following Viatris' agreement to acquire the company for $36.50 per share, valuing the deal at approximately $1.65 billion. Other notable gainers included Profound Medical, which rose 21.7% after forecasting Q3 revenue above expectations, and WISeSat.Space, which climbed 41.6% on news of an upcoming satellite launch. These moves highlight strong investor confidence driven by acquisition news and positive revenue forecasts.
Top stock gainers on October 8, 2026, saw notable moves in the market. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 09, 2026 03:21 WIB: out of 128 priced US health stocks, 51 rose and 76 fell. CVS Health Corp traded at USD 83.45 with a 1-day change of -5.12%, Immunovant Inc. Common Stock at USD 30.43 with -5.02%, and Hims and Hers Health Inc at USD 28.07 with -4.99%.
On October 8, 2026, several stocks including AngioDynamics, Apimeds Pharmaceuticals US, and Arqit Quantum experienced steep declines of over 18%, despite some positive financial reports. Leveraged ETFs CRWG and IRE also dropped 15.5%, highlighting th...
Bitcoin dropped nearly 2% to $81,723, leading a broad decline in the crypto market which saw total capitalization fall over 5% to $2.78 trillion. Ether, XRP, BNB, Solana, and Dogecoin also experienced significant losses, with NEAR Protocol falling ov...
On October 8, seven major Bitcoin transfers moved a total of $652 million between unknown wallets and crypto exchanges within three hours. Notably, $401 million flowed from unknown wallets to exchanges, while $251 million moved out, resulting in a ne...
West Fraser Timber Co. Ltd. will announce its third quarter 2026 financial and operating results on October 28, 2026. The company will hold an analyst conference call the following day, October 29, to discuss these results and answer questions. This ...
Sun Life Financial has alerted its shareholders about an unsolicited mini-tender offer from Ocehan LLC to buy up to 100,000 shares at nearly 25% below recent market prices. Sun Life does not endorse this offer and advises shareholders to be cautious,...
